Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
LLY Stock Gains 4% to All-Time High: Is Obesity Access the Catalyst?
11:51am, Friday, 29'th May 2026
Eli Lilly hits a record high after CVS expands coverage for Foundayo and Zepbound, boosting obesity drug access and raising the stakes in its rivalry with NVO.
Lilly Reopens Zepbound Access For 10 Million US Patients
09:22am, Friday, 29'th May 2026
Eli Lilly (LLY) is getting a major access win in the obesity drug market after CVS Health reversed its earlier restriction on Zepbound across certain drug plans
Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
05:24pm, Thursday, 28'th May 2026
Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win
09:45am, Thursday, 28'th May 2026
Eli Lilly continues strong execution, exceeding revenue expectations and expanding its pipeline with strategic, low-risk acquisitions in infectious diseases and other areas. LLY's infectious disease d
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost
08:07am, Thursday, 28'th May 2026
Expense ratios, yield, and sector breadth set these healthcare ETFs apart-see how their risk profiles and portfolio strategies compare.
CVS brings back coverage for Lilly's obesity drug Zepbound
06:47am, Thursday, 28'th May 2026
CVS Health said on Thursday it will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional preferred option for insurance coverage.
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
06:45am, Thursday, 28'th May 2026
CVS Health said it will restore coverage of Eli Lilly's blockbuster weight loss injection Zepbound and start covering its new obesity pill on its standard drug plans. The move supports Lilly's efforts
Foundayo and Zepbound now covered for millions of Americans
06:45am, Thursday, 28'th May 2026
CVS Caremark begins covering Foundayo June 1 and resumes Zepbound coverage by October 1 Eligible patients may pay as low as $25 a month for their medicine INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- El
Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion
05:40pm, Wednesday, 27'th May 2026
Eli Lilly (LLY) stock has surged to new record highs of over $1,000 a share, cementing its position as one of the market's most dominant growth stories and the first pharmaceutical firm worth $1 trill
President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?
02:02pm, Wednesday, 27'th May 2026
Eli Lilly's fundamentals matter more than Trump's stock purchases.
Eli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts
01:35pm, Wednesday, 27'th May 2026
LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.
Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference
11:15am, Wednesday, 27'th May 2026
INDIANAPOLIS, May 27, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Kenneth Custer, executive vi
Healthy Returns: Eli Lilly makes a new push into vaccines – here's what to know
10:57am, Wednesday, 27'th May 2026
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
10:50am, Wednesday, 27'th May 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine
10:08am, Wednesday, 27'th May 2026
Eli Lilly agreed to acquire Bothell, Wash.
